SClMED STOCK KEEPS MOMENTUM IN SEPTEMBER, JUMPING 19% TO 43- 3/4
This article was originally published in The Gray Sheet
SClMED STOCK KEEPS MOMENTUM IN SEPTEMBER, JUMPING 19% TO 43- 3/4, a 7 point gain. The increase made the issue the largest point gainer on "The Gray Sheet" Index of O-T-C traded stocks. The September advance builds on 6-3/8 point gains in both August and July; together, the summer upswings reverse declines experienced since January, when the issue closed the month at 42-1/2.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.